Showing results (11-20 of 1,607) with videos related to

Sort By:
Pageof 161
Medizinische Klinik (Munich, Germany : 1983)|October 12, 2000
[Homocysteine and its metabolites in chronic renal insufficiency and the effect of a vitamin replacement]B F Henning, M Tepel, U Graefe, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|May 4, 2001
Identification of quercetin glucuronides in human plasma by high-performance liquid chromatography-tandem mass spectrometryJ Wittig, M Herderich, E U Graefe, et al.
Klinische Monatsblatter Fur Augenheilkunde|November 1, 1986
[Incidence of conjunctival and corneal changes in dialysis patients]K H Emmerich, D Vondracek, H Raidt, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|April 2, 2002
Comparison of antioxidative capacities and inhibitory effects on cholesterol biosynthesis of quercetin and potential metabolitesG Glässer, E U Graefe, F Struck, et al.
Research in Experimental Medicine. Zeitschrift Fur Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie|June 28, 2001
Homocyst(e)ine metabolism in hemodialysis patients treated with vitamins B6, B12 and folateB F Henning, W Zidek, R Riezler, et al.
Medizinische Klinik (Munich, Germany : 1983)|November 15, 1990
[Long-term results following kidney transplantation. An empirical analysis of 467 allogeneic kidney transplants concerning the effect of clinical and immunological variables on graft function]K Langer, B Buchholz, H Raidt, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 26, 2010
Effect of linagliptin (BI 1356) on the steady-state pharmacokinetics of simvastatinU Graefe-Mody, S Huettner, H Stähle, et al.
Clinical Science (London, England : 1979)|June 1, 1992
Isolation of an ultrafilterable Ca(2+)-ATPase inhibitor from the plasma of uraemic patientsW Zidek, T Rustemeyer, W Schlüter, et al.
Journal of Clinical Pharmacology|September 25, 2008
Safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of BI 1356, an inhibitor of dipeptidyl peptidase 4, in healthy male volunteersS Hüttner, E U Graefe-Mody, B Withopf, et al.
Current Medical Research and Opinion|June 26, 2009
Evaluation of the potential for steady-state pharmacokinetic and pharmacodynamic interactions between the DPP-4 inhibitor linagliptin and metformin in healthy subjectsE U Graefe-Mody, S Padula, A Ring, et al.
Pageof 161